date,title,source
Oct-18-18,NovoCure (NVCR) Q3 Earnings Preview: What to Look Out For,Zacks
Oct-22-18,Pancreatology Publishes Results of the PANOVA Phase 2 Pilot Trial in Advanced Pancreatic Cancer Suggesting Improved Survival of Patients Treated with Tumor Treating Fields,Business Wire
Oct-23-18,Higher Delivered Dose of Tumor Treating Fields to Tumor Bed Associated with Improved Overall Survival in Newly Diagnosed Glioblastoma,Business Wire
Oct-24-18,"Novocure Founder Professor Yoram Palti and Director Louis J. Lavigne, Jr. Retire from Board of Directors",Business Wire
Oct-25-18,Here's Why Novocure Is Tumbling Today,Motley Fool
Oct-25-18,"NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Oct-25-18,Novocure Reports Third Quarter 2018 Financial Results and Provides Company Update,Business Wire
